# Advances in Elucidating the Mitochondrial DNA Mechanisms Underlying Ozone-Induced Inflammation

**Authors:** Qianhui Chen, Hao Liu, Junhe Zhou, Yongjie Wei, Lingyan He

PMC · DOI: 10.3390/toxics14030248 · Toxics · 2026-03-12

## TL;DR

This paper reviews how mitochondrial DNA might be involved in inflammation caused by ozone exposure.

## Contribution

The paper provides a review of how mitochondrial DNA functions as a mediator in ozone-induced inflammation.

## Key findings

- Ozone exposure may lead to mitochondrial dysfunction and mtDNA release.
- mtDNA could act as a damage-related molecular pattern triggering inflammation.
- The paper reviews mechanisms linking ozone exposure to inflammatory responses.

## Abstract

Ground-level ozone is widely acknowledged as one of the primary air pollutants, capable of inducing adverse health effects across multiple human systems, including asthma, cardiovascular events, and central nervous system dysfunction. Epidemiological and toxicological studies indicate that the onset of related systemic diseases is often attributed to ozone-mediated inflammatory responses. However, since O3 itself lacks antigenic properties to trigger innate immune responses, an intermediary substance induced by ozone exposure likely activates subsequent inflammatory pathways. Multiple ozone exposure studies have identified mitochondrial DNA (mtDNA) as a potential biomarker released during ozone-induced mitochondrial dysfunction. mtDNA may serve as a damage-related molecular pattern that activates innate immune responses, potentially acting as a crucial link between ozone and inflammatory reactions. This review therefore examines the structure and function of mitochondrial DNA, along with potential mediating mechanisms underlying inflammation associated with ozone exposure.

## Linked entities

- **Chemicals:** ozone (PubChem CID 24823)
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 498840] {aka RGD1562552, Tmem173, rSTING}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, FEN1 (flap structure-specific endonuclease 1) [NCBI Gene 2237] {aka FEN-1, MF1, RAD2}, MCU (mitochondrial calcium uniporter) [NCBI Gene 90550] {aka C10orf42, CCDC109A, HsMCU}, SLC8B1 (solute carrier family 8 member B1) [NCBI Gene 80024] {aka NCKX6, NCLX, SLC24A6}, ATAD3B (ATPase family AAA domain containing 3B) [NCBI Gene 83858] {aka AAA-TOB3, TOB3}, OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976] {aka BERHS, MGM1, MTDPS14, MTDPS14A, MTDPS14B, NPG}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, UQCC2 (ubiquinol-cytochrome c reductase complex assembly factor 2) [NCBI Gene 84300] {aka C6orf125, C6orf126, Cbp6, M19, MC3DN7, MNF1}, SLC25A6 (solute carrier family 25 member 6) [NCBI Gene 293] {aka AAC3, ANT, ANT 2, ANT 3, ANT3, ANT3Y}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, PPIF (peptidylprolyl isomerase F) [NCBI Gene 10105] {aka CYP3, CyP-M, Cyp-D, CypD}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578] {aka BAK, BAK-LIKE, BCL2L7, CDN1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, IFN1@ (interferon, type 1, cluster) [NCBI Gene 3438] {aka IFNA}, POLRMT (RNA polymerase mitochondrial) [NCBI Gene 5442] {aka APOLMT, COXPD55, MTRNAP, MTRPOL, h-mtRPOL}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, DNM1L (dynamin 1 like) [NCBI Gene 10059] {aka DLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1}, NEK7 (NIMA related kinase 7) [NCBI Gene 140609], IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, ND3 (NADH dehydrogenase subunit 3) [NCBI Gene 4537] {aka MTND3}, IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654] {aka IRAK, pelle}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, n-TGacc1 (nuclear encoded tRNA glycine 1 (anticodon ACC)) [NCBI Gene 102467526] {aka n-Tg1}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, TFAM (transcription factor A, mitochondrial) [NCBI Gene 7019] {aka MTDPS15, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2}, CYTB (cytochrome b) [NCBI Gene 4519] {aka MTCYB}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, FIS1 (fission, mitochondrial 1) [NCBI Gene 51024] {aka CGI-135, TTC11}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}
- **Diseases:** rhinitis (MESH:D012220), tissue damage (MESH:D017695), cancer (MESH:D009369), metabolic dysfunction (MESH:D008659), autoimmune conditions (MESH:D001327), cardiovascular systems (MESH:D018376), systemic diseases (MESH:D034721), cardiac remodeling (MESH:D020257), myocardial ischemia (MESH:D017202), skin allergies (MESH:D012871), Inflammatory (MESH:D007249), conjunctivitis (MESH:D003231), breast cancer (MESH:D001943), infectious diseases (MESH:D003141), fetal growth restriction (MESH:D005317), asthma (MESH:D001249), neurological, respiratory, and cardiovascular diseases (MESH:D012140), mitochondrial structural and functional abnormalities (MESH:C566527), tumorigenesis (MESH:D063646), death (MESH:D003643), hyperpigmentation (MESH:D017495), injury to (MESH:D014947), infection (MESH:D007239), mitochondrial damage (MESH:D028361), diabetes (MESH:D003920), COPD (MESH:D029424), atherogenesis (MESH:D050197), elevated blood (MESH:D006402), neurodegeneration (MESH:D019636), central nervous system dysfunction (MESH:D002493), coronary artery disease (MESH:D003324), cardiovascular disease (MESH:D002318), toxicity (MESH:D064420), damage to the (MESH:D020263), lung injury (MESH:D055370)
- **Chemicals:** oils (MESH:D009821), cardiolipin (MESH:D002308), hydrogen peroxide (MESH:D006861), SO2 (MESH:D013458), lead (MESH:D007854), glutathione (MESH:D005978), hydroxyl (MESH:D017665), ROS (MESH:D017382), CpG (MESH:C015772), CO (MESH:D002248), phosphatidic acid (MESH:D010712), cyclosporin A (MESH:D016572), copper (MESH:D003300), ATP (MESH:D000255), lipopolysaccharide (MESH:D008070), vitamin C (MESH:D001205), 8-OH-dG (MESH:D000080242), VOCs (MESH:D055549), Cyclic guanosine monophosphate (MESH:D006152), carbon (MESH:D002244), oxygen (MESH:D010100), O3 (MESH:D010126), superoxide anions (MESH:D013481), hydrogen (MESH:D006859), dGTP (MESH:C029603), calcium (MESH:D002118), cGAMP (-), deoxyribose (MESH:D003855), lipid (MESH:D008055), iron (MESH:D007501), NOx (MESH:D009589), cytosine (MESH:D003596), adenine (MESH:D000225)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13030118/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13030118/full.md

## References

202 references — full list in the complete paper: https://tomesphere.com/paper/PMC13030118/full.md

---
Source: https://tomesphere.com/paper/PMC13030118